Published in J Carcinog on February 14, 2003
Cell cycle regulation and apoptosis. Annu Rev Physiol (1998) 2.25
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J Biol Chem (2000) 1.22
The site of the action of rotenone in the respiratory chain. Exp Cell Res (1961) 1.19
Suppression of liver DNA synthesis by cortisone. Endocrinology (1971) 1.18
Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Cancer Res (1998) 1.09
Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver. Cancer Lett (1995) 1.03
Dioxins and endometriosis: a plausible hypothesis. Environ Health Perspect (2002) 0.95
Hormone-induced changes in liver DNA synthesis: effects of glucocorticoids and growth hormone on liver growth and DNA polymerase activity. Endocrinology (1974) 0.88
Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone. Carcinogenesis (1997) 0.85
Production and inhibition of hypertensive disease in the rat by corticosterone. Endocrinology (1958) 0.84
Hepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53. Mol Cancer (2003) 0.84
p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments. Anticancer Res (1998) 0.81
Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone. Mol Cell Biochem (1999) 0.81
Carcinogenesis: The more we seek to know the more we need to know - Challenges in the post Genomic Era. J Carcinog (2003) 0.80
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol Cell Biol (2004) 4.41
Outcomes of prenatal antidepressant exposure. Am J Psychiatry (2002) 3.07
FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. Cancer Res (2008) 2.46
The FaceBase Consortium: a comprehensive program to facilitate craniofacial research. Dev Biol (2011) 2.16
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Case-control study of neurodevelopment in deformational plagiocephaly. Pediatrics (2010) 1.77
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet (2012) 1.74
Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol Pathol (2002) 1.72
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res (2004) 1.72
Mutation discovery in mice by whole exome sequencing. Genome Biol (2011) 1.69
Neurodevelopment of children with single suture craniosynostosis: a review. Childs Nerv Syst (2006) 1.53
Development in toddlers with and without deformational plagiocephaly. Arch Pediatr Adolesc Med (2011) 1.44
Microtia: epidemiology and genetics. Am J Med Genet A (2011) 1.42
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol (2005) 1.42
Primary pulmonary dysgenesis in velocardiofacial syndrome: a second patient. Am J Med Genet A (2003) 1.42
Maternal and infant characteristics associated with prone and lateral infant sleep positioning in Washington state, 1996-2002. J Pediatr (2008) 1.41
Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci (2004) 1.39
Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. Am J Med Genet A (2007) 1.37
Protein dynamics in the nuclear compartment. Curr Opin Genet Dev (2002) 1.37
Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol (2006) 1.37
Neurodevelopment of infants with single-suture craniosynostosis: presurgery comparisons with case-matched controls. Plast Reconstr Surg (2007) 1.36
Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstet Gynecol (2009) 1.31
Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol (2006) 1.28
Presurgical and postsurgical assessment of the neurodevelopment of infants with single-suture craniosynostosis: comparison with controls. J Neurosurg (2007) 1.28
Gene expression response in target organ and whole blood varies as a function of target organ injury phenotype. Genome Biol (2008) 1.28
Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene (2005) 1.22
New scaphocephaly severity indices of sagittal craniosynostosis: a comparative study with cranial index quantifications. Cleft Palate Craniofac J (2006) 1.22
Characteristics of 2733 cases diagnosed with deformational plagiocephaly and changes in risk factors over time. Cleft Palate Craniofac J (2008) 1.21
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A (2014) 1.20
Chromatin dynamics and the evolution of alternate promoter states. Chromosome Res (2006) 1.19
Copy number variation analysis in single-suture craniosynostosis: multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis. Am J Med Genet A (2010) 1.19
Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem (2002) 1.17
Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. J Biol Chem (2006) 1.17
Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci (2006) 1.16
Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter. Mol Biol Cell (2008) 1.16
Heterozygous mutations of FREM1 are associated with an increased risk of isolated metopic craniosynostosis in humans and mice. PLoS Genet (2011) 1.13
Picture perfect? Reliability of craniofacial anthropometry using three-dimensional digital stereophotogrammetry. Plast Reconstr Surg (2009) 1.12
A human homeotic transformation resulting from mutations in PLCB4 and GNAI3 causes auriculocondylar syndrome. Am J Hum Genet (2012) 1.07
Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control. J Biomed Biotechnol (2004) 1.05
Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc (2013) 1.04
The flame retardants, polybrominated diphenyl ethers, are pregnane X receptor activators. Toxicol Sci (2007) 1.04
Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol Sci (2007) 1.04
Parameters of care for craniosynostosis. Cleft Palate Craniofac J (2011) 1.03
"Mandibulofacial dysostosis with microcephaly" caused by EFTUD2 mutations: expanding the phenotype. Am J Med Genet A (2012) 1.02
Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data. Toxicol Pathol (2004) 1.01
Vitamin A depletion induced by cigarette smoke is associated with the development of emphysema in rats. J Nutr (2003) 1.01
Chemical effects in biological systems--data dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes, and 'omics data. Toxicol Sci (2005) 1.01
Multicenter study of neurodevelopment in 3-year-old children with and without single-suture craniosynostosis. Arch Pediatr Adolesc Med (2012) 1.01
Reading in children with orofacial clefts versus controls. J Pediatr Psychol (2009) 1.00
Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis? Am J Med Genet A (2005) 1.00
Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia. Inflammation (2002) 1.00
Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene (2004) 1.00
Subnuclear trafficking and gene targeting by steroid receptors. Ann N Y Acad Sci (2004) 1.00
Effects of dietary calorie restriction or exercise on the PI3K and Ras signaling pathways in the skin of mice. J Biol Chem (2007) 0.98
Captopril prevents experimental autoimmune myocarditis. J Immunol (2003) 0.98
Capillary sieving electrophoresis/micellar electrokinetic capillary chromatography for two-dimensional protein fingerprinting of single mammalian cells. Anal Chem (2004) 0.98
Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Exp Biol Med (Maywood) (2003) 0.97
MDCT diagnosis of the child with posterior plagiocephaly. AJR Am J Roentgenol (2005) 0.97
Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene (2004) 0.96
Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes. Birth Defects Res A Clin Mol Teratol (2011) 0.96
The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release. Mol Cell Biol (2007) 0.96
Progressive postnatal craniosynostosis and increased intracranial pressure. Plast Reconstr Surg (2004) 0.96
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. Br J Pharmacol (2011) 0.95
Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem (2006) 0.95
Ultrasound screening of the lambdoid suture in the child with posterior plagiocephaly. Pediatr Radiol (2003) 0.94
Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet (2003) 0.94
Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens. Carcinogenesis (2004) 0.94
Pulmonary agenesis: expansion of the VCFS phenotype. Am J Med Genet (2002) 0.94
Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study. Crit Rev Toxicol (2013) 0.93
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. Birth Defects Res A Clin Mol Teratol (2005) 0.93
In vitro differentiation profile of osteoblasts derived from patients with Saethre-Chotzen syndrome. Bone (2005) 0.93
Further characterization of atypical features in auriculocondylar syndrome caused by recessive PLCB4 mutations. Am J Med Genet A (2013) 0.92
Bilateral lambdoid and sagittal synostosis (BLSS): a unique craniosynostosis syndrome or predictable craniofacial phenotype? Am J Med Genet A (2009) 0.92
Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis (2003) 0.92
Familial acromelic frontonasal dysostosis: autosomal dominant inheritance with reduced penetrance. Am J Med Genet A (2004) 0.92
Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern Lab Anim (2006) 0.91
Development at age 36 months in children with deformational plagiocephaly. Pediatrics (2012) 0.91
Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome. J Med Genet (2013) 0.91
New severity indices for quantifying single-suture metopic craniosynostosis. Neurosurgery (2008) 0.91
Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver. Toxicol Appl Pharmacol (2008) 0.90
Fat embolism: evolution of histopathological changes in the rat lung. J Orthop Res (2010) 0.90
Robin sequence: from diagnosis to development of an effective management plan. Pediatrics (2011) 0.89
Genotype-phenotype analysis of the branchio-oculo-facial syndrome. Am J Med Genet A (2011) 0.89
Perspectives and challenges in advancing research into craniofacial anomalies. Am J Med Genet C Semin Med Genet (2013) 0.89
Differential expression of extracellular matrix-mediated pathways in single-suture craniosynostosis. PLoS One (2011) 0.89
WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase. Toxicol Sci (2007) 0.88
Hemifacial microsomia in pediatric patients: asymmetric abnormal development of the first and second branchial arches. AJR Am J Roentgenol (2002) 0.87
ALX4 gain-of-function mutations in nonsyndromic craniosynostosis. Hum Mutat (2012) 0.87
Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des (2003) 0.87
Severity of skull malformation is unrelated to presurgery neurobehavioral status of infants with sagittal synostosis. Cleft Palate Craniofac J (2007) 0.86
Preferential associated anomalies in 818 cases of microtia in South America. Am J Med Genet A (2013) 0.86
Comparison of computed tomographic imaging measurements with clinical findings in children with unilateral lambdoid synostosis. Plast Reconstr Surg (2009) 0.86
Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression. Toxicol Appl Pharmacol (2007) 0.85
Human consumption of methyleugenol and its elimination from serum. Environ Health Perspect (2004) 0.85
Dental anomalies in a child with craniometaphysial dysplasia. Pediatr Dent (2007) 0.85
Senescence-associated decline in hepatic peroxisomal enzyme activities corresponds with diminished levels of retinoid X receptor alpha, but not peroxisome proliferator-activated receptor alpha. Mech Ageing Dev (2002) 0.85
Mitigating effects of captopril and losartan on lung histopathology in a rat model of fat embolism. J Trauma (2011) 0.84
Longitudinal, three-dimensional analysis of head shape in children with and without deformational plagiocephaly or brachycephaly. J Pediatr (2011) 0.84